Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services symbols : Brtx save search
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 7.58%
H: 16.2%
C: -7.75%
brtx-100 fda clearance study
BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: -1.5%
H: 0.0%
C: -2.29%
brtx-100 disease trial
BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants
Published: 2024-04-03 (Crawled : 21:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 2.29%
H: 1.49%
C: 0.0%
BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: -2.17%
H: 3.71%
C: 3.7%
report
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
Published: 2024-03-11 (Crawled : 20:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 3.13%
H: 1.14%
C: 0.0%
conference
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
Published: 2024-02-06 (Crawled : 13:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: -55.07%
H: 6.45%
C: 1.29%
million
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
Published: 2024-02-05 (Crawled : 12:30) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 14.64%
H: 14.33%
C: 7.48%
brtx-100 disease study
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
Published: 2024-02-01 (Crawled : 12:30) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 7.98%
H: 35.69%
C: 22.73%
brtx-100 research meeting
BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program
Published: 2023-12-12 (Crawled : 14:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 10.34%
H: 3.65%
C: -4.17%
obesity patent application program
BioRestorative Therapies, Inc. to Participate at the ROTH MKM Healthcare Opportunities Conference October 12, 2023 in New York City
Published: 2023-10-09 (Crawled : 16:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 1.88%
C: 0.94%
conference city
BioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics
Published: 2023-09-12 (Crawled : 13:30) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 6.45%
H: 0.0%
C: -17.68%
agreement
BioRestorative Therapies Announces Activation of Northwell Health in the Company's Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease
Published: 2023-09-08 (Crawled : 12:30) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 1.59%
H: 0.0%
C: -6.88%
disease health trial phase 2
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform - Insights From The Discussion
Published: 2023-07-31 (Crawled : 13:00) - biospace.com/
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 1.05%
H: 2.08%
C: 0.35%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
care specialist
BioRestorative Therapies (NASDAQ:BRTX) Receives Landmark License From New York State
Published: 2023-07-21 (Crawled : 12:20) - biospace.com/
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 0.66%
H: 0.0%
C: -5.94%
state license
BioRestorative Therapies Announces $2.1 Million Registered Direct Offering
Published: 2023-07-11 (Crawled : 12:20) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: -14.89%
H: 3.96%
C: 1.98%
direct offering
BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities
Published: 2023-07-07 (Crawled : 13:20) - biospace.com/
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 0.49%
H: 1.93%
C: -7.71%
brtx-100 drug candidate test pipeline
BioRestorative Therapies Receives Unanimous Recommendation from Data Safety Monitoring Board (DSMB) to Continue its Phase 2 Clinical Trial without any Changes
Published: 2023-06-27 (Crawled : 11:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 4.78%
H: 2.65%
C: -27.35%
trial
BioRestorative Therapies, Inc. to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
Published: 2023-06-16 (Crawled : 11:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 1.4%
H: 8.13%
C: 8.13%
conference group
BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease
Published: 2023-06-12 (Crawled : 11:00) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 0.57%
H: 1.7%
C: 0.57%
disease trial milestone phase 2
BioRestorative Therapies, Inc. to attend the Jefferies 2023 Healthcare Conference
Published: 2023-06-01 (Crawled : 13:20) - globenewswire.com
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 1.15%
H: 2.46%
C: 1.71%
conference
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.